# TAVALISSE

NDC: 71332-002
Generic name: FOSTAMATINIB
Labeler / Manufacturer: Rigel Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180509

FDA application: NDA209299

## Active ingredients

- FOSTAMATINIB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71332-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71332-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21149cc3-049b-43e2-b141-c9499160556c